Paeds Vivas · infectious-diseases
Travel medicine and pre-travel advice for children — branching viva
Branching structured-oral viva on the pre-travel consultation for children: the composite risk score, the four-lane plan, age-appropriate chemoprophylaxis, the vaccine age thresholds, the visiting-friends-and-relatives family, the XDR typhoid standby-therapy implication, and the fever-after-travel safety net.
On this page & tools
Target exams
Opening question
Examiner: How will you structure the pre-travel consultation for this family? [1]
Candidate: The frame is a structured risk-reduction encounter, not a vaccine checklist. I build a composite risk score from the destination, the type of travel and the child, then deliver four parallel lanes — immunisation, prophylaxis, behavioural and environmental protection, and a written response kit. This family is a visiting-friends-and-relatives group travelling for a month to rural Bangladesh, which is the single highest-risk and most-often-missed category for imported paediatric malaria and typhoid, so I will give the full four-lane plan with particular attention to prophylaxis adherence and the fever-after-travel rule. [2]
Examiner: Why is the VFR family the highest-risk group? [2]
Candidate: Migrant families returning to a country of origin with non-immune children born in Australia stay longer, travel more intensely than tourists, have higher rural exposure, and are less likely to have sought pre-travel advice, because the parents underestimate the risk to a child who has never lived in the endemic setting. The systematic review of children returning to Europe confirms the burden falls heaviest on this group. The system-level fix is to ask the VFR question in primary care and to build outreach to migrant communities. [2] [5]
Branch 1 — chemoprophylaxis and age
Examiner: What malaria prophylaxis will you give this four-year-old? [4]
Candidate: Atovaquone-proguanil is the default. Rural Bangladesh is chloroquine-resistant, doxycycline is avoided under eight years, and mefloquine carries neuropsychiatric contraindications and a longer lead-in time. Atovaquone-proguanil is licensed from five kilograms, is well tolerated, and requires only one day of pre-exposure and seven days of post-travel dosing, which aids adherence. I start it before exposure, continue through the trip and for one week after return, and address adherence explicitly because a regimen not completed is the commonest reason for breakthrough infection. [4]
Examiner: And if the child were ten years old and the family preferred a weekly drug? [4]
Candidate: Mefloquine is weekly and an option from this age, but I would screen for neuropsychiatric history (depression, anxiety, seizures) and start it two to three weeks before departure to confirm tolerability. Doxycycline is also an option from eight years but is daily, photosensitising, and must continue for four weeks after return. For most families the daily atovaquone-proguanil with its short post-travel tail remains the most adherence-friendly choice. [4]
Branch 2 — vaccines and age thresholds
Examiner: Which travel vaccines will you offer and what age thresholds govern them? [6]
Candidate: Hepatitis A from one year of age, injectable typhoid (Vi conjugate or polysaccharide) from two years, and Japanese encephalitis vaccine (Ixiaro) from two months for a prolonged rural-Asia stay. I will also catch up the missing routine immunisations, especially measles-mumps-rubella before travel to an endemic region. The four-to-six-week window allows a primary series to begin, and the first dose confers at least partial protection. [6]
Examiner: What if the destination required a yellow fever certificate? [6]
Candidate: Yellow fever vaccine is given from nine months where a certificate is required, and is contraindicated below that age, in significant immunocompromise, and in thymus disorder. For a child under nine months facing a yellow-fever-certified destination, the answer is a medical waiver and a route change, not a contraindicated vaccine. I would also check that oral typhoid is not given under six years or to the immunocompromised child, because it is a live vaccine. [6]
Branch 3 — XDR typhoid and the standby antibiotic
Examiner: What will you give the family for standby treatment of travellers' diarrhoea? [3]
Candidate: Oral rehydration salts for all, with a standby antibiotic for severe or bloody diarrhoea or persistent fever — and the antibiotic choice is a travel-history decision. For South Asia, where extensively drug-resistant Salmonella Typhi is now prevalent and resistant to fluoroquinolones and often third-generation cephalosporins, azithromycin is the safer empiric choice rather than a fluoroquinolone. I write the fever-after-travel rule in the family's language: if the child becomes febrile within months of return, seek care immediately and state the destination. [3] [4]
Examiner: Why has XDR typhoid reshaped the standby message? [3]
Candidate: Because a fluoroquinolone given empirically to a child with XDR typhoid acquired in South Asia may not cover the strain, and the child could deteriorate before culture returns. The GeoSentinel analysis of enteric fever in international travellers documented the rising resistance and the geographic pattern, which is why the empiric standby antibiotic is now destination-driven. [3]
Branch 4 — the last-minute traveller
Examiner: Suppose the family arrives the day before departure. What do you do? [6]
Candidate: I do not turn them away. I deliver the prophylaxis and behavioural lanes in full, give the first dose of every available vaccine, and arrange the remaining doses to be completed at the destination or on return. The message is that partial protection plus behaviour plus a fever plan is far better than nothing. The one thing I will not do is give a contraindicated vaccine or an age-inappropriate drug to save time — the age-and-contraindication check happens regardless of the timeline. [6]
Examiner: And the single most important message to this family? [4]
Candidate: The fever-after-travel rule. If the child develops a fever within months of return from a malaria-endemic area, seek medical care immediately, state the destination, and ask for a malaria blood film. Falciparum malaria is a time-critical killer, the pre-travel plan exists to prevent it, and the family who knows the rule is the family whose child is diagnosed and treated before harm. [4] [1]
Wrap
Examiner: Summarise the pre-travel consultation in one sentence. [1]
Candidate: Assess the destination, the type of travel and the child to build a risk score, deliver the four parallel lanes of immunisation, prophylaxis, behavioural protection and a written response kit with age-appropriate choices, and give every family the fever-after-travel rule — because the pre-travel encounter exists to stop the child from ever needing a same-day malaria film. [1] [6]
References
- [1]Freedman DO; Weld LH; Kozarsky PE; Fisk T; et al Spectrum of disease and relation to place of exposure among ill returned travelers N Engl J Med, 2006.PMID 16407507
- [2]Bacaner N; Stauffer B; Boulware DR; Walker PF; et al Travel medicine considerations for North American immigrants visiting friends and relatives JAMA, 2004.PMID 15199037
- [3]Hagmann SHF; Angelo KM; Huits R; Plewes K; et al Epidemiological and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of Their Isolates: a GeoSentinel Analysis Antimicrob Agents Chemother, 2020.PMID 32816733
- [4]Kiang KM; Bryant PA; Shingadia D; Ladhani S; et al The treatment of imported malaria in children: an update Arch Dis Child Educ Pract Ed, 2013.PMID 23171589
- [5]Niestępski J; Baran JM; Waszak Z; Jarzębska J; et al Epidemiology and Spectrum of Imported Infectious Diseases in Children and Adolescents Returning to Europe: A Systematic Review Pathogens, 2026.PMID 42347233
- [6]Halsey ES; Angelo KM; Barnett ED; Chen LH; et al Traveling Safely with Infants and Children CDC Health Information for International Travel, 2025.PMID 41818599